These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28356586)

  • 1. TransCelerate makes progress.
    Mullard A
    Nat Rev Drug Discov; 2017 Mar; 16(4):229. PubMed ID: 28356586
    [No Abstract]   [Full Text] [Related]  

  • 2. Garry Neil. Interview by Asher Mullard.
    Neil G
    Nat Rev Drug Discov; 2012 Nov; 11(11):826. PubMed ID: 23123934
    [No Abstract]   [Full Text] [Related]  

  • 3. At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products.
    Varmaghani M; Heidari E; Reiner Ž; Sahebkar A
    J Med Econ; 2020 Oct; 23(10):1193-1195. PubMed ID: 32580595
    [No Abstract]   [Full Text] [Related]  

  • 4. Busting the billion-dollar myth: how to slash the cost of drug development.
    Maxmen A
    Nature; 2016 Aug; 536(7617):388-90. PubMed ID: 27558048
    [No Abstract]   [Full Text] [Related]  

  • 5. Re-inventing clinical trials through TransCelerate.
    Gill D
    Nat Rev Drug Discov; 2014 Nov; 13(11):787-8. PubMed ID: 25359361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative effort.
    Novak K
    Nat Rev Cancer; 2002 Sep; 2(9):638. PubMed ID: 12240637
    [No Abstract]   [Full Text] [Related]  

  • 7. Deal watch: co-promotion deals: panacea or poison pill?
    Borshell N; Papp T
    Nat Rev Drug Discov; 2010 Nov; 9(11):831. PubMed ID: 21030991
    [No Abstract]   [Full Text] [Related]  

  • 8. Creating more paths to hope.
    Hale V
    Newsweek; 2004 Dec; 144(23):80. PubMed ID: 15605728
    [No Abstract]   [Full Text] [Related]  

  • 9. Piercing the veil of corporate secrecy about clinical trials.
    Lemmens T
    Hastings Cent Rep; 2004; 34(5):14-8. PubMed ID: 15553393
    [No Abstract]   [Full Text] [Related]  

  • 10. Geron-Roslin alliance aims broadly at degenerative diseases.
    Fox JL
    Nat Biotechnol; 1999 Jun; 17(6):529-30. PubMed ID: 10385308
    [No Abstract]   [Full Text] [Related]  

  • 11. The value proposition of investigator-initiated clinical trials conducted by networks.
    joint ACTA/ACSQHC Working Group
    Med J Aust; 2021 Mar; 214(4):159-161.e1. PubMed ID: 33583043
    [No Abstract]   [Full Text] [Related]  

  • 12. Making drugs, not profits.
    Stix G
    Sci Am; 2004 May; 290(5):42-4. PubMed ID: 15127660
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials in India: balancing economic opportunity with the public health context.
    Dandona L
    Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS vaccine duo.
    Nature; 2005 Jun; 435(7046):1159. PubMed ID: 15988492
    [No Abstract]   [Full Text] [Related]  

  • 15. Importancia de la investigación clínica independiente en la medicina: dificultades y recomendaciones.
    Arrieta O; Campillo C; Burgos R; Celis MÁ; Llata M; Domínguez J; Halabe J; Islas S; Jasso L; Lifshitz A; Moreno M; Plancarte R; Reyes-Sánchez A; Ruiz-Argüelles GJ; Soda A; Verástegui E; Sotelo J
    Gac Med Mex; 2019; 155(3):319-321. PubMed ID: 31219475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World CAB. Focus on international drug pricing.
    GMHC Treat Issues; 2004; 18(1-2):8-13. PubMed ID: 15119275
    [No Abstract]   [Full Text] [Related]  

  • 17. New image for the drug industry.
    Cohen D
    BMJ; 2011 Nov; 343():d7713. PubMed ID: 22127772
    [No Abstract]   [Full Text] [Related]  

  • 18. The synergy of the whole: building a global system for clinical trials to accelerate medicines development.
    Koski G; Tobin MF; Whalen M
    Clin Ther; 2014 Oct; 36(10):1356-70. PubMed ID: 25444565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACCESS oncology and Zentaris sign product partnership.
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):484. PubMed ID: 12382516
    [No Abstract]   [Full Text] [Related]  

  • 20. Leaders worry that U.S. is losing edge on cancer clinical trials.
    Twombly R
    J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.